| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―Mar―19 |
Pathological impact of SARS-CoV-2 viroporin on the cardiomyocyte function |
Jin O-Uchi, Bong Sook Jhun |
| 2 |
[GO] |
2025―Dec―20 |
SARS-CoV-2-infected cardiomyocytes exhibit upregulated necroptosis, but no evidence of mitochondrial permeability transition |
C. Gross, S. Chatterjee, B.E. Nilsson-Payant, S.D. Stojanović, H. Kefalakes, C. Bär, T. Thum, T. Pietschmann, J. Bauersachs, G. Amanakis |
| 3 |
[GO] |
2025―Jun―24 |
Proteomic Insights into Cardiometabolic Remodeling in SARS-CoV-2-Infected Hamsters |
Sogol Sedighi, Ting Liu, Deepthi Ashok, Meghana Prakash, Alexis Tensfeldt, Agnieska Sidor, D.Brian Foster, Brian O'Rourke |
| 4 |
[GO] |
2025―Jun―24 |
Myocardial Dysfunction in a Syrian Hamster model with COVID-19 |
Cesar Zoni, Namakkal Rajasekaran, Yi Xue, Lillian Zalduando, Chittoor Sai Sudhakar, Colleen Jonsson, Yazhini Ravi |
| 5 |
[GO] |
2024―Dec―22 |
Association of LEF1-AS1 with cardiovascular and neurological complications of COVID-19 |
Mélanie Vausort, Andrew I. Lumley, Hassina Boubakeur, Lu Zhang, Feng Q. Hefeng, Markus Ollert, Paul Wilmes, Guy Fagherazzi, Yvan Devaux |
| 6 |
[GO] |
2024―Dec―20 |
10043: Prevalence of hypercoagulation in post-acute COVID-19 patients and efficacy of novel anticoagulants as therapeutics in a human ex vivo thrombosis model |
Dan Liao, Aaron Wei Liang Li, Cinthia Wan Ting Phua, Cheryl Xue Pei Chuah, Xiao Xun Yang, Tammy Xin Tian Low, Matthew Benson, Shoumo Bhattacharya, R. Manjunatha Kini, Mark Yan Yee Chan, Cho Yeow Koh |
| 7 |
[GO] |
2022―Jul―28 |
(Epi)transcriptomics in cardiovascular and neurological complications of COVID-19 |
Amela Jusic, Konstantinos Stellos, Lino Ferreira, Andrew H. Baker, Yvan Devaux |
|
